Strategies for Filing Patent Applications Globally: Expanding Your Innovation’s Horizon

You’ve built something original – a process, a device, a formulation – and the Indian market is just one piece of a much larger commercial picture. Your product could compete in the US, Europe, Japan, or Southeast Asia. But protecting your invention in those markets isn’t automatic. A patent granted by the Indian Patent Office only gives you rights within India. If you want enforceable protection elsewhere, you need to file in those countries separately – and that requires a clear strategy from the outset. For Indian inventors, two primary routes exist: the direct national filing route and the Patent Cooperation Treaty (PCT) route. Choosing between them – or combining them – can significantly impact your costs, timelines, and commercial flexibility.

The first checkpoint: foreign filing license 🔗

Before an Indian inventor files a patent application in any foreign country, there’s a mandatory legal requirement to address. Under Section 39 of the Indian Patents Act, 1970, any person who is a resident of India must either file the patent application in India first and wait six weeks – or obtain a Foreign Filing License (FFL) from the Indian Patent Office before filing abroad. This applies regardless of whether you’re filing directly in a foreign country or under the PCT.

The FFL is applied for using Form 25, and the Controller of Patents is ordinarily required to respond within 21 days. The purpose is to ensure that inventions with potential defence or strategic value are reviewed domestically before being disclosed internationally. Non-compliance carries serious consequences: under Section 118 of the Patents Act, failing to obtain an FFL can result in imprisonment for up to two years, a fine, or both – and can even lead to revocation of any patent already granted. The safest practical approach for most inventors is to file in India first, wait the six-week period, and then proceed with international filings.

Route 1: direct national filing (the Paris Convention route) 🔗

The most straightforward way to seek protection abroad is to file directly in each country where you want patent rights. India is a member of the Paris Convention for the Protection of Industrial Property, which gives Indian applicants a significant procedural advantage: once you file in India, you have 12 months from that priority date to file corresponding applications in other Paris Convention member countries. Those later filings are treated as if they were made on the same date as the Indian application – protecting you from any disclosures or competing filings that occur in between.

This route works well when you already know exactly which markets matter to you commercially and are ready to commit to those jurisdictions within the year. If you are targeting one or two specific countries, the direct filing route can be more cost-effective than the PCT, since you avoid paying PCT filing fees on top of national fees. The tradeoff, however, is immediacy: you must engage local patent attorneys, pay country-specific fees, and comply with each office’s procedural requirements – all within that tight 12-month window.

When does direct filing make sense? 🔗

Direct national filing is most suitable when your commercial strategy is already well-defined. If an Indian pharma startup knows it needs protection in the US and Germany and nowhere else, filing directly in those jurisdictions through the Paris Convention route is faster and avoids the administrative overhead of the PCT process. Direct filings can also expedite the patent grant process by 18 months or more compared to the PCT route, since there is no international phase to wait through.

Route 2: the PCT route 🔗

The Patent Cooperation Treaty (PCT), administered by the World Intellectual Property Organization (WIPO), offers a different approach to international patent protection – one that prioritises time and strategic flexibility. Rather than filing separate applications in each country within 12 months, the PCT allows you to file a single international application that covers over 158 member countries. This does not grant you an international patent – no such thing exists – but it gives you a legally recognised filing with a preserved priority date, while deferring the obligation to enter individual national offices.

The PCT process unfolds in two distinct phases:

The international phase 🔗

After filing your PCT application (with the Indian Patent Office acting as the Receiving Office, or directly with WIPO), the application undergoes an International Search conducted by a designated International Searching Authority (ISA). The ISA prepares an International Search Report (ISR) and a written opinion on whether the invention appears to be novel, inventive, and industrially applicable. If you choose to pursue it further, an International Preliminary Examination can be requested from an International Preliminary Examining Authority (IPEA), which produces an International Preliminary Examination Report (IPER).

These reports are not binding on national patent offices, but they serve a critical strategic function: they offer valuable insights into the novelty and inventiveness of your application before you commit to expensive national filings. If the ISR reveals significant prior art that undermines your claims, you can decide to withdraw or refine your application before incurring the costs of national phase entry in multiple countries. Conversely, a favourable written opinion strengthens your confidence to proceed broadly.

The application is published 18 months from the priority date, providing public notice of your intent to seek protection – and effectively preventing others from independently patenting the same invention in many jurisdictions.

The national phase 🔗

The real decision-making comes at the end of the international phase. Applicants have up to 30 or 31 months from the earliest priority date to enter the national phase in each country where they seek protection. This is the point at which you engage local patent attorneys, pay country-specific fees, file translations where required, and comply with individual national examination procedures. Each national office then conducts its own examination based on your PCT application.

This extended timeline – nearly two and a half years from your initial filing – is the PCT’s most significant advantage. It provides breathing room to conduct market research, validate commercial potential, secure investor interest, and align patent strategy with business development before committing to the substantial costs of national filings.

Why the PCT route offers a strategic edge for Indian inventors 🔗

For most Indian inventors and startups who are uncertain about which global markets will prove commercially viable, the PCT route offers a more forgiving path. Filing a PCT application within the same 12-month priority period gives you a further 18 months to file in foreign countries, bringing the total window to 30 months from the original priority date. That is 18 additional months compared to the Paris Convention direct route.

Several specific advantages make the PCT route particularly valuable:

Deferred costs: National phase entry in each country is expensive – local attorney fees, translations, and official examination fees add up quickly. The PCT defers a significant portion of these costs to later stages, allowing inventors to delay financial commitment until they have better information about commercial viability. For startups managing limited capital, this can be the difference between preserving options and overcommitting prematurely.

Informed decision-making: The ISR and written opinion give you a preliminary read on patentability across jurisdictions. If the report is favourable, you proceed with confidence. If prior art is identified, you can amend claims during the international phase to improve your chances before entering national offices – a far more efficient use of resources than discovering problems country by country after expensive filings.

Jurisdictional flexibility: The PCT allows applicants to retain flexibility in selecting specific countries for national phase prosecution based on evolving commercial and legal considerations. You are not locked into a fixed set of countries at the time of filing – you designate the countries you might want and make final decisions much later.

Simplified administration: Rather than coordinating simultaneous filings in multiple languages and formats across different offices, you manage a single application during the international phase. The administrative burden is concentrated early, and dispersed later when you have clearer strategic direction.

Higher perceived valuation: PCT applications generally attract higher valuation compared to non-PCT applications, particularly in startup and investment contexts. Investors often view a PCT application as a signal of global intent and broader commercial potential.

Direct filing vs PCT: how to decide 🔗

The right choice depends on your specific situation. A well-designed international patent strategy is not about filing everywhere – it is about filing wisely. Here are the key factors to weigh:

Number of target countries: If you are targeting only one or two countries and know exactly which ones, direct filing under the Paris Convention is often more economical since you avoid PCT fees. If you are considering three or more markets – or are unsure – the PCT generally becomes more cost-efficient in the long run.

Commercial certainty: If your business plan is clearly defined and market validation is complete, direct filing gets you to a granted patent faster. If you are still testing the market or seeking investors, the PCT’s extended timeline is a structural advantage.

Technology sensitivity: For high-value technology with broad global applicability – pharmaceuticals, AI, semiconductors – the PCT’s preliminary examination reports are particularly useful in refining claims before entering multiple competitive national offices.

Budget and cash flow: The PCT does not eliminate costs; it delays them. The total cumulative cost of PCT national phase entries in multiple countries can exceed the cost of direct filings. However, deferring costs is often essential for early-stage inventors who need time to raise capital or generate revenue before committing to large international patent budgets.

Combining both routes: a practical strategy 🔗

The two routes are not mutually exclusive. For Indian startups with inventions targeting the domestic market but with international scalability, a combined approach is often optimal: file provisionally in India to secure the priority date, use the 12-month Paris Convention window to file directly in a key confirmed market (such as the US), and simultaneously file a PCT application to preserve options in other markets where viability is still being assessed. This structure gives you immediate protection where you need it and strategic flexibility everywhere else.

It is also worth noting that India joined the PCT as a contracting state on December 7, 1998, and has grown significantly as both a filing origin and a designated office. The Indian Patent Office serves as an International Searching Authority, meaning PCT applicants can designate it for their international search – a procedurally efficient option that can also help accelerate domestic prosecution in India.

Key compliance points to keep in mind 🔗

Whether you choose the direct route or the PCT, a few procedural requirements are non-negotiable for Indian residents. The Foreign Filing License must be addressed before any international filing. The priority date established by your first filing – whether provisional or complete – is the anchor for all subsequent filings. Missing the 12-month Paris Convention deadline or the 30/31-month PCT national phase deadline results in an irreversible loss of rights in those countries. Unlike the US, India does not permit retroactive FFL requests – which makes compliance from the outset essential rather than optional.

Working with a registered Indian patent agent, and coordinating with foreign associates in key jurisdictions, is strongly advisable for any international filing strategy. The procedural requirements vary significantly across national offices, and errors made during the international phase can be costly and difficult to correct.

What do you think? If you were an early-stage startup with a potentially patentable invention and limited capital, would you prioritise filing in a few key markets directly or use the PCT’s extended window to gather more market data before committing? And given that the PCT ultimately requires separate national phase filings anyway, at what point does the cost of the PCT process outweigh its strategic benefits?

References

1. https://ssrana.in/ip-laws/patents/ffl-foreign-filing-license-patent-india/
2. https://www.lexology.com/library/detail.aspx?g=b97d1466-f68b-47a3-83d9-8433ab28a9c7
3. https://stratjuris.com/international-patent-filing-pct-vs-direct-filing/
4. https://www.seedip.com/posts/strategic-considerations-for-international-patent-filings-exploring-the-pct-vs-direct-filing-routes-by-seed-ip-partner-bobby-soltani
5. https://www.wipo.int/pct/en/
6. https://www.barandbench.com/view-point/international-patent-filing-and-registration-pct-vs-direct
7. https://ssrana.in/ip-laws/patents/pct-national-phase-application-india/
8. https://depenning.com/blog/the-patent-cooperation-treaty-pct-and-global-patent-filing-strategy-for-indian-inventors/
9. https://ip-coster.com/academy/details/pct_or_paris_convention
10. https://www.rkdewan.com/blogs/strategic-patent-filing-india-national-pct-guide/
11. https://www.rkdewan.com/blogs/optimizing-global-patent-filing-pathways/
12. https://www.iam-media.com/index.php/guide/india-managing-the-ip-lifecycle/2026/article/registration-routes-in-the-indian-market-and-how-use-them-build-strong-prosecution-strategy
13. https://www.intepat.com/blog/pct-patent-india
14. https://kankrishme.com/foreign-filing-license-for-patents-in-india/